Annual Total Long Term Liabilities
$621.00 K
-$381.00 K-38.02%
31 December 2023
Summary:
Aptose Biosciences annual total long term liabilities is currently $621.00 thousand, with the most recent change of -$381.00 thousand (-38.02%) on 31 December 2023. During the last 3 years, it has risen by +$86.00 thousand (+16.07%). APTO annual total long term liabilities is now -95.15% below its all-time high of $12.81 million, reached on 31 May 2008.APTO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$10.30 M
+$9.89 M+2389.13%
30 September 2024
Summary:
Aptose Biosciences quarterly total long term liabilities is currently $10.30 million, with the most recent change of +$9.89 million (+2389.13%) on 30 September 2024. Over the past year, it has increased by +$9.59 million (+1331.25%). APTO quarterly long term liabilities is now -19.59% below its all-time high of $12.81 million, reached on 31 May 2008.APTO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | +1331.3% |
| 3 y3 years | +16.1% | +4627.1% |
| 5 y5 years | +100.0% | +816.8% |
APTO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.0% | +440.0% | at high | >+9999.0% |
| 5 y | 5 years | -38.6% | at high | >+9999.0% | |
| alltime | all time | -95.2% | >+9999.0% | -19.6% | >+9999.0% |
Aptose Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.30 M(+2389.1%) |
| June 2024 | - | $414.00 K(-20.4%) |
| Mar 2024 | - | $520.00 K(-16.3%) |
| Dec 2023 | $621.00 K(-38.0%) | $621.00 K(-13.8%) |
| Sept 2023 | - | $720.00 K(-11.9%) |
| June 2023 | - | $817.00 K(-11.0%) |
| Mar 2023 | - | $918.00 K(-8.4%) |
| Dec 2022 | $1.00 M(+771.3%) | $1.00 M(>+9900.0%) |
| Sept 2022 | - | $1000.00(-66.7%) |
| June 2022 | - | $3000.00(-70.0%) |
| Mar 2022 | - | $10.00 K(-91.3%) |
| Dec 2021 | $115.00 K(-78.5%) | $115.00 K(-47.2%) |
| Sept 2021 | - | $218.00 K(-32.1%) |
| June 2021 | - | $321.00 K(-23.6%) |
| Mar 2021 | - | $420.00 K(-21.5%) |
| Dec 2020 | $535.00 K(-47.1%) | $535.00 K(-18.7%) |
| Sept 2020 | - | $658.00 K(-15.2%) |
| June 2020 | - | $776.00 K(-13.2%) |
| Mar 2020 | - | $894.00 K(-11.6%) |
| Dec 2019 | $1.01 M(>+9900.0%) | $1.01 M(-10.1%) |
| Sept 2019 | - | $1.12 M(-7.5%) |
| June 2019 | - | $1.22 M(-8.1%) |
| Mar 2019 | - | $1.32 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | - |
| Sept 2014 | - | $0.00(-100.0%) |
| May 2014 | $486.60 K | $486.60 K(-18.6%) |
| Feb 2014 | - | $597.70 K(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2013 | - | $615.10 K(>+9900.0%) |
| Aug 2013 | - | $0.00(0.0%) |
| May 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2013 | - | $0.00(0.0%) |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | - | $0.00(0.0%) |
| May 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) |
| May 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) |
| May 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2010 | - | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) |
| Aug 2009 | - | $0.00(0.0%) |
| May 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Feb 2009 | - | $0.00(-100.0%) |
| Aug 2008 | - | $12.35 M(-3.6%) |
| May 2008 | $12.81 M(+18.5%) | $12.81 M(+0.5%) |
| Feb 2008 | - | $12.74 M(+4.8%) |
| Nov 2007 | - | $12.16 M(+8.3%) |
| Aug 2007 | - | $11.23 M(+3.8%) |
| May 2007 | $10.81 M(+8.2%) | $10.81 M(+8.3%) |
| Feb 2007 | - | $9.98 M(-0.5%) |
| Nov 2006 | - | $10.03 M(-1.2%) |
| Aug 2006 | - | $10.15 M(+1.6%) |
| May 2006 | $9.99 M(+22.8%) | $9.99 M(+5.5%) |
| Feb 2006 | - | $9.47 M(+8.2%) |
| Aug 2005 | - | $8.76 M(+7.6%) |
| May 2005 | $8.14 M(<-9900.0%) | $8.14 M(+51.5%) |
| Feb 2005 | - | $5.37 M(+103.9%) |
| Nov 2004 | - | $2.63 M(<-9900.0%) |
| Aug 2003 | - | -$1000.00(0.0%) |
| Feb 2003 | - | -$1000.00(0.0%) |
| May 2002 | -$1000.00(0.0%) | -$1000.00(-200.0%) |
| Aug 2001 | - | $1000.00(-200.0%) |
| May 2001 | -$1000.00(-101.5%) | -$1000.00(-242.9%) |
| Nov 2000 | - | $700.00(-99.0%) |
| Aug 1999 | - | $66.90 K(-1.3%) |
| May 1999 | $67.80 K | $67.80 K(-204.1%) |
| Nov 1998 | - | -$65.10 K |
FAQ
- What is Aptose Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aptose Biosciences?
- What is Aptose Biosciences annual total long term liabilities year-on-year change?
- What is Aptose Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aptose Biosciences?
- What is Aptose Biosciences quarterly long term liabilities year-on-year change?
What is Aptose Biosciences annual total long term liabilities?
The current annual total long term liabilities of APTO is $621.00 K
What is the all time high annual total long term liabilities for Aptose Biosciences?
Aptose Biosciences all-time high annual total long term liabilities is $12.81 M
What is Aptose Biosciences annual total long term liabilities year-on-year change?
Over the past year, APTO annual total long term liabilities has changed by -$381.00 K (-38.02%)
What is Aptose Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of APTO is $10.30 M
What is the all time high quarterly long term liabilities for Aptose Biosciences?
Aptose Biosciences all-time high quarterly total long term liabilities is $12.81 M
What is Aptose Biosciences quarterly long term liabilities year-on-year change?
Over the past year, APTO quarterly total long term liabilities has changed by +$9.59 M (+1331.25%)